Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

South Dakota Soybean Processors (SDSYA) Other Accumulated Expenses (2016 - 2025)

South Dakota Soybean Processors has reported Other Accumulated Expenses over the past 16 years, most recently at $8.0 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 73.22% year-over-year to $8.0 million; the TTM value through Dec 2025 reached $8.0 million, up 73.22%, while the annual FY2025 figure was $8.0 million, 73.22% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $8.0 million at South Dakota Soybean Processors, up from $5.7 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $8.0 million in Q4 2025 and troughed at $2.5 million in Q2 2021.
  • A 5-year average of $4.6 million and a median of $4.3 million in 2023 define the central range for Other Accumulated Expenses.
  • Biggest five-year swings in Other Accumulated Expenses: soared 81.13% in 2022 and later plummeted 31.19% in 2024.
  • Year by year, Other Accumulated Expenses stood at $4.3 million in 2021, then skyrocketed by 40.8% to $6.1 million in 2022, then rose by 10.84% to $6.7 million in 2023, then plummeted by 31.19% to $4.6 million in 2024, then skyrocketed by 73.22% to $8.0 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for SDSYA at $8.0 million in Q4 2025, $5.7 million in Q3 2025, and $4.7 million in Q2 2025.